BTG

(redirected from BTG plc)
Also found in: Dictionary, Wikipedia.

BTG

A British pharmaceutical company. It develops drugs for cancer, neurological disorders and other diseases and sells them to hospitals and others. It traces its origins to the 1940s and was founded in its current form in 1991 as the British Technology Group. It is publicly traded and is included on the FTSE 250.

BTG

see BRITISH TECHNOLOGY GROUP.
References in periodicals archive ?
Boston Scientific plans to acquired BTG plc for GBP3.3 billion (approximately USD4.2 billion) in cash in H1'19.
Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc.
has entered into an agreement to divest its Targeted Therapies business to BTG plc, a specialist healthcare company based in London, for $200 million in cash.
Working with pharmaceuticals company BTG plc in Wales, they were advised how the business closely monitored discharge from its waste water treatment plant to ensure it remained within discharge consent limits.
(a subsidiary of BTG plc (London, United Kingdom), a leading international technology transfer company, announced that it has signed a nonexclusive licensing agreement with Pasteur Merieux Connaught (Gulph Mills, PA; 610-313-4030), the world's leading vaccine company, granting rights to a fatty acid carrier technology for synthetic vaccines.
M2 PRESSWIRE-August 23, 2019-: Interventional Oncology Market: Big Players Focusing On Product Advancements For Business Expansion 2019-2025 - BTG plc, Medtronic, Boston Scientific, Terumo, Merit Medical, Sirtex, AngioDynamics
M2 EQUITYBITES-August 19, 2019-Boston Scientific acquires BTG plc
Soderstrom was chief financial officer of specialist healthcare company BTG PLC from 2008 until 2018
Net proceeds from the offering may be used to finance a portion of the proposed acquisition of BTG plc, to redeem its 6.000% notes due January 2020 and its 2.850% notes due May 2020 (collectively, the 2020 notes), repay amounts outstanding under its USD1.0bn term loan facility maturing August 2019, repay other short term debt as well as pay related fees, expenses and premiums.
Healthcare company BTG plc (LSE:BTG) said on Monday that an Australian patient has been dosed with its DC Bead LUMI for the local treatment of hepatocellular carcinoma (HCC) and liver metastases from colorectal cancer (mCRC), respectively.
Key players profiled in the report include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories.
Boston Scientific announced it has reached an agreement on the terms of a recommended offer to acquire BTG plc., a company headquartered in the United Kingdom, which develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as acute care pharmaceuticals.